Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy.

Literature DB >> 1666349

A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy.

S Maccari¹, C Bassi, A G Giovannini, A C Plancher.

Abstract

Late side effects of alpha-interferon therapy include some autoimmune diseases, such as thyroiditis. We present the case of a patient with severe chronic active hepatitis and hepatitis-C-virus positivity, who during alpha-interferon therapy developed an autoimmune thyroiditis and at the same time arthropathy with some characteristics of rheumatoid arthritis (several articular stations simultaneously affected, involvement of the hand joints and morning stiffness).

Entities: Disease Species

Mesh：

Substances：

Year: 1991 PMID： 1666349 DOI： 10.1007/bf02206672

Source DB: PubMed Journal: Clin Rheumatol ISSN： 0770-3198 Impact factor: 2.980

11 in total

Review 1. Side effects of alpha interferon.

Authors: P F Renault; J H Hoofnagle
Journal: Semin Liver Dis Date: 1989-11 Impact factor: 6.115

2. An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer.

Authors: I S Fentiman; F R Balkwill; B S Thomas; M J Russell; I Todd; G F Bottazzo
Journal: Eur J Cancer Clin Oncol Date: 1988-08

3. Alpha-interferon and immune hemolytic anemia.

Authors: L P Akard; R Hoffman; L Elias; J H Saiers
Journal: Ann Intern Med Date: 1986-08 Impact factor: 25.391

4. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.

Authors: W J Mayet; G Hess; G Gerken; S Rossol; R Voth; M Manns; K H Meyer zum Büschenfelde
Journal: Hepatology Date: 1989-07 Impact factor: 17.425

5. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal: Arthritis Rheum Date: 1988-03

6. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors: G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal: N Engl J Med Date: 1989-11-30 Impact factor: 91.245

7. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy.

Authors: K C Conlon; W J Urba; J W Smith; R G Steis; D L Longo; J W Clark
Journal: Cancer Date: 1990-05-15 Impact factor: 6.860

8. Interferon-induced aplasia: evidence for T-cell-mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin.

Authors: K F Mangan; B Zidar; R K Shadduck; Z Zeigler; A Winkelstein
Journal: Am J Hematol Date: 1985-08 Impact factor: 10.047

A case of arthropathy and hypothyroidism during recombinant alpha-interferon therapy.

Review 1. Side effects of alpha interferon.

2. An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer.

3. Alpha-interferon and immune hemolytic anemia.

4. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.

5. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

6. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

7. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy.

8. Interferon-induced aplasia: evidence for T-cell-mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin.

9. Psoriasis and alpha-interferon.

10. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon.

1. Autoimmune hepatitis and thyroiditis associated with rifampin and pyrazinamide prophylaxis: an unusual reaction.

Review 2. [Interferon therapy and autoimmunity].

3. Hypothyroidism and arthritis during interferon therapy.

Review 4. Clinical toxicity of the interferons.

5. Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon.